1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Global Atherectomy and Thrombectomy Devices Market 2015-2019

Global Atherectomy and Thrombectomy Devices Market 2015-2019

  • August 2015
  • -
  • Infiniti Research Limited
  • -
  • 81 pages

About Atherectomy and Thrombectomy Devices
Atherectomy devices are used to remove atherosclerotic plaques to clear blocked blood vessels. Atherosclerotic plaques are deposits of fats, calcium, or other substances inside the blood vessels. It is an endovascular procedure for the treatment of PAD and CAD. PVD refers to damaged or blocked peripheral blood vessels that supply blood to the arms, legs, and organs other than brain and heart. PAD, which is PVD of the arteries, is known to increase the risk of stroke and heart attack by up to six times. CAD is a condition of narrowing of arteries that supply blood to heart muscles. Stents, balloon catheters, atherectomy devices are used in endovascular procedures to treat PVD. Thrombectomy devices are used to surgically remove thrombi (clot) from the blood vessels during the treatment of DVT. DVT is the blood clot formed in deep veins in the body, mainly in legs. The risk of developing these vascular diseases increases with age. Diabetes, high blood pressure, obesity, and smoking are other risk factors for these diseases.

Technavio's analysts forecast the global atherectomy and thrombectomy market to grow at a CAGR of 6.25% over the period 2014-2019.


Covered in this Report
The report includes the present scenario and the growth prospects of the global atherectomy and thrombectomy devices market for the period 2015-2019. The market can be segmented into two divisions: atherectomy devices and thrombectomy devices.

Technavio's report, Global Atherectomy and Thrombectomy Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global atherectomy and thrombectomy devices market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.


Key Regions
- Americas
- APAC
- EMEA

Key Vendors
- Boston Scientific Group
- Cardiovascular Systems
- Medtronic
- Spectranetics

Other Prominent Vendors
- Argon Medical Devices
- C.R. Bard
- Cod Man Neuro (DePuy Orthopaedics)
- Cook Medical
- Edwards Lifesciences
- IDEV Technologies (subsidiary of Abbott Vascular)
- Lake Region Medical
- NexGen Medical Systems
- Reverse Medical
- St. Jude Medical
- Teleflex Medical
- Volcano (acquired by Philips)

Key Market Driver
- Growing Prevalence of PAD and DVT
- For a full, detailed list, view our report

Key Market Challenge
- Product Recalls
- For a full, detailed list, view our report

Key Market Trend
- Growing Number of Acquisitions
- For a full, detailed list, view our report


Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Table Of Contents

Global Atherectomy and Thrombectomy Devices Market 2015-2019
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
03.2.1 Atherectomy Products
03.2.2 Thrombectomy Products
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Global Atherectomy and Thrombectomy Devices Market
06.1 Market Overview
06.1.1 Market Size and Forecast
07. Global Atherectomy and Thrombectomy Market Segmentation by Product Type
07.1 Atherectomy Devices
07.2 Thrombectomy Devices
07.3 Five Forces Analysis
08. Global Atherectomy Devices Market
08.1 Market Overview
08.1.1 Market Size and Forecast
08.2 Market Segmentation by Procedure Type
09. Global Thrombectomy Devices Market
09.1 Market Overview
09.1.1 Market Size and Forecast
09.2 Market Segmentation by Product Type
09.3 Market Segmentation by Procedure Type
10. Reimbursement Scenario of Atherectomy and Thrombectomy Devices
10.1 Reimbursement Scenario in Americas
10.2 Reimbursement Scenario in EMEA
10.3 Reimbursement Scenario in APAC
11. Geographical Segmentation
11.1 Atherectomy and Thrombectomy Devices Market in Americas
11.1.1 Market Size and Forecast
11.2 Atherectomy and Thrombectomy Devices Market in EMEA
11.2.1 Market Size and Forecast
11.3 Atherectomy and Thrombectomy Devices Market in APAC
11.3.1 Market Size and Forecast
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers and Acquisitions
19.2 Vendor Analysis 2015
19.2.1 Boston Scientific Group
19.2.2 Cardiovascular Systems
19.2.3 Medtronic
19.2.4 Spectranetics
19.2.5 Other Prominent Vendors
20. Key Vendor Analysis
20.1 Boston Scientific Group
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation
20.1.4 Business Strategy
20.1.5 Business Segmentation by Revenue
20.1.6 Business Segmentation by Revenue 2012 and 2013
20.1.7 Geographical Segmentation by Revenue
20.1.8 Key Developments
20.1.9 SWOT Analysis
20.2 Cardiovascular Systems
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Product Segmentation Based on Therapy Areas
20.2.4 Business Strategy
20.2.5 Recent Developments
20.2.6 SWOT Analysis
20.3 Medtronic
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation by Revenue 2013
20.3.4 Business Segmentation by Revenue 2012 and 2013
20.3.5 Geographical Segmentation by Revenue 2013
20.3.6 Business Strategy
20.3.7 Recent Developments
20.3.8 SWOT Analysis
20.4 Spectranetics
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation 2014
20.4.4 Business Segmentation by Revenue 2013 and 2014
20.4.5 Geographical Segmentation by Revenue 2014
20.4.6 Business Strategy
20.4.7 Recent Developments
20.4.8 SWOT Analysis
21. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Atherectomy and Thrombectomy Devices Market 2014-2019 ($ million)
Exhibit 3: Global Atherectomy and Thrombectomy Devices Market: Segmentation by Product Type
Exhibit 4: Global Atherectomy and Thrombectomy Devices Market 2014
Exhibit 5: Global Atherectomy Devices Market 2014-2019 ($ million)
Exhibit 6: Global Atherectomy Devices Market: Segmentation by Procedure Type
Exhibit 7: Global Thrombectomy Devices Market 2014-2019 ($ million)
Exhibit 8: Global Thrombectomy Devices Market: Segmentation by Product Type
Exhibit 9: Segmentation of Global Thrombectomy Devices Market by Procedure Type
Exhibit 10: Global Atherectomy and Thrombectomy Devices Market 2014-2019
Exhibit 11: Global Atherectomy and Thrombectomy Devices Market 2014-2019($ million)
Exhibit 12: Reimbursement for Atherectomy (Medicare)
Exhibit 13: Reimbursement for Thrombectomy (Medicare)
Exhibit 14: Geographical Segmentation of Global Atherectomy and Thrombectomy Devices Market 2014
Exhibit 15: Atherectomy and Thrombectomy Devices Market in Americas 2014-2019 ($ million)
Exhibit 16: Atherectomy and Thrombectomy Devices Market in EMEA 2014-2019 ($ million)
Exhibit 17: Atherectomy and Thrombectomy Devices Market in APAC 2014-2019 ($ million)
Exhibit 18: Geographical Segmentation of Global Atherectomy and Thrombectomy Devices Market 2014-2019
Exhibit 19: Geographical Segmentation of Global Atherectomy and Thrombectomy Devices Market 2014-2019 ($ million)
Exhibit 20: Key Takeaways: Boston Scientific Group
Exhibit 21: Key Takeaways: Cardiovascular Systems
Exhibit 22: Key Takeaways: Medtronic
Exhibit 23: Key Takeaways: Spectranetics
Exhibit 24: Boston Scientific: Business Segmentation 2013
Exhibit 25: Boston Scientific: Business Segmentation by Revenue 2013
Exhibit 26: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 27: Boston Scientific: Geographical Segmentation by Revenue 2012 and 2013 2013
Exhibit 28: Cardiovascular Systems: Product Segmentation Based on Therapy Areas
Exhibit 29: Medtronic: Business Segmentation by Revenue 2013
Exhibit 30: Medtronic: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 31: Medtronic: Geographical Segmentation by Revenue 2013
Exhibit 32: Spectranetics: Business Segmentation 2014
Exhibit 33: Spectranetics: Business Segmentation by Revenue 2013 and 2014 ($ million)
Exhibit 34: Spectranetics: Geographical Segmentation by Revenue 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Cardiovascular Surgical Devices: Technologies and Global Markets

Cardiovascular Surgical Devices: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about the trends and developments affecting each type of cardiovascular surgical technology - Analyze trends and opportunities in major regions: North America, Europe, Asia ...

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) & by Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The nuclear medicine/radiopharmaceuticals market is projected to reach USD 7.27 billion by 2021 from USD 4.67 billion in 2016, growing at a CAGR of 9.3% in the next five years (2016 to 2021). Over the ...

Refurbished Medical Equipment Market: By Type (Medical Imaging, Operating Room & Surgical, Patient Monitors, Cardiovascular & Cardiology, Defibrillators, Neurology, Others) & By Region-Forecast (2016-2021)

Refurbished Medical Equipment Market: By Type (Medical Imaging, Operating Room & Surgical, Patient Monitors, Cardiovascular & Cardiology, Defibrillators, Neurology, Others) & By Region-Forecast (2016-2021)

  • $ 5250
  • Industry report
  • September 2016
  • by Industry ARC

Refurbished medical equipment market is being primarily driven by factors like development of e-commerce platform enhancing the ease of purchase of refurbished medical equipment, growing demand for refurbished ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.